Belleri M - Search Results

1

The Pro-Oncogenic Sphingolipid-Metabolizing Enzyme β-Galactosylceramidase Modulates the Proteomic Landscape in BRAF(V600E)-Mutated Human Melanoma Cells.

Capoferri D, Chiodelli P, Corli M, Belleri M, Scalvini E, Mignani L, Guerra J, Grillo E, De Giorgis V, Manfredi M, Presta M. Capoferri D, et al. Among authors: belleri m. Int J Mol Sci. 2023 Jun 23;24(13):10555. doi: 10.3390/ijms241310555. Int J Mol Sci. 2023. PMID: 37445731 Free PMC article.

2

Noncompetitive, chemokine-mediated inhibition of basic fibroblast growth factor-induced endothelial cell proliferation.

Presta M, Belleri M, Vecchi A, Hesselgesser J, Mantovani A, Horuk R. Presta M, et al. Among authors: belleri m. J Biol Chem. 1998 Apr 3;273(14):7911-9. doi: 10.1074/jbc.273.14.7911. J Biol Chem. 1998. PMID: 9525887 Free article.

3

Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process.

Presta M, Rusnati M, Belleri M, Morbidelli L, Ziche M, Ribatti D. Presta M, et al. Among authors: belleri m. Cancer Res. 1999 May 15;59(10):2417-24. Cancer Res. 1999. PMID: 10344752

4

Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells.

Dell'Era P, Belleri M, Stabile H, Massardi ML, Ribatti D, Presta M. Dell'Era P, et al. Among authors: belleri m. Oncogene. 2001 May 10;20(21):2655-63. doi: 10.1038/sj.onc.1204368. Oncogene. 2001. PMID: 11420677

5

Anti-angiogenic activity of the purine analog 6-thioguanine.

Presta M, Belleri M, Vacca A, Ribatti D. Presta M, et al. Among authors: belleri m. Leukemia. 2002 Aug;16(8):1490-9. doi: 10.1038/sj.leu.2402646. Leukemia. 2002. PMID: 12145690

6

Antiangiogenic and vascular-targeting activity of the microtubule-destabilizing trans-resveratrol derivative 3,5,4'-trimethoxystilbene.

Belleri M, Ribatti D, Nicoli S, Cotelli F, Forti L, Vannini V, Stivala LA, Presta M. Belleri M, et al. Mol Pharmacol. 2005 May;67(5):1451-9. doi: 10.1124/mol.104.009043. Epub 2005 Feb 9. Mol Pharmacol. 2005. PMID: 15703378

7

Cutting edge: extracellular high mobility group box-1 protein is a proangiogenic cytokine.

Mitola S, Belleri M, Urbinati C, Coltrini D, Sparatore B, Pedrazzi M, Melloni E, Presta M. Mitola S, et al. Among authors: belleri m. J Immunol. 2006 Jan 1;176(1):12-5. doi: 10.4049/jimmunol.176.1.12. J Immunol. 2006. PMID: 16365390

8

Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor.

Stabile H, Mitola S, Moroni E, Belleri M, Nicoli S, Coltrini D, Peri F, Pessi A, Orsatti L, Talamo F, Castronovo V, Waltregny D, Cotelli F, Ribatti D, Presta M. Stabile H, et al. Among authors: belleri m. Blood. 2007 Mar 1;109(5):1834-40. doi: 10.1182/blood-2006-06-032276. Epub 2006 Oct 31. Blood. 2007. PMID: 17077323 Free article.

9

Angiopoietin-1 mediates the proangiogenic activity of the bone morphogenic protein antagonist Drm.

Mitola S, Moroni E, Ravelli C, Andres G, Belleri M, Presta M. Mitola S, et al. Among authors: belleri m. Blood. 2008 Aug 15;112(4):1154-7. doi: 10.1182/blood-2007-09-111450. Epub 2008 May 27. Blood. 2008. PMID: 18505784 Free article.

10

A pro-inflammatory signature mediates FGF2-induced angiogenesis.

Andrés G, Leali D, Mitola S, Coltrini D, Camozzi M, Corsini M, Belleri M, Hirsch E, Schwendener RA, Christofori G, Alcamì A, Presta M. Andrés G, et al. Among authors: belleri m. J Cell Mol Med. 2009 Aug;13(8B):2083-2108. doi: 10.1111/j.1582-4934.2008.00415.x. J Cell Mol Med. 2009. PMID: 18624773 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters